StreetInsider.com News Articles

Form 4 ZEVRA THERAPEUTICS, INC. For: May 28 Filed by: Sangiovanni Timothy J.

Fri, 29 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260529/26575415.html

Form 4 ZEVRA THERAPEUTICS, INC. For: May 28 Filed by: Sangiovanni Timothy J.

Fri, 29 May 2026 16:17:00 -0400

si-local-file:///var/storage/secattach/20260529/26575415.html

Form 4 ZEVRA THERAPEUTICS, INC. For: May 11 Filed by: Thompson Rahsaan

Wed, 13 May 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260513/26486796.html

Form 4 ZEVRA THERAPEUTICS, INC. For: May 11 Filed by: Thompson Rahsaan

Wed, 13 May 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260513/26486796.html

Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference

Tue, 12 May 2026 07:30:00 -0400

BOSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra’s executive leadership team will present at the H.C. Wainwright BioConnect Investor Conference in New York, NY on Tuesday, May 19, 2026, at 9:00 a.m. ET.

Additionally, management will be available for one-on-one meetings with registered conference attendees. A link to the live webcast will be accessible on the “Events & Presentations” page in the Investor Relations

Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference

Tue, 12 May 2026 07:30:00 -0400

Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference

Tue, 12 May 2026 07:30:00 -0400

Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference

Tue, 12 May 2026 07:30:00 -0400

Form 144 ZEVRA THERAPEUTICS, INC. Filed by: Thompson Rahsaan

Mon, 11 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260511/26469839.html

Form 144 ZEVRA THERAPEUTICS, INC. Filed by: Thompson Rahsaan

Mon, 11 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260511/26469839.html

Zevra Therapeutics, Inc. (ZVRA) PT Raised to $25 at Guggenheim

Fri, 08 May 2026 07:21:54 -0400

Guggenheim analyst Eddie Hickman raised the price target on Zevra Therapeutics, Inc. (NASDAQ: ZVRA) to $25.00 (from $23.00) while maintaining a Buy rating.

Form 10-Q ZEVRA THERAPEUTICS, INC. For: Mar 31

Wed, 06 May 2026 17:14:00 -0400

si-local-file:///var/storage/secattach/20260506/26445451.html

Form 10-Q ZEVRA THERAPEUTICS, INC. For: Mar 31

Wed, 06 May 2026 17:14:00 -0400

si-local-file:///var/storage/secattach/20260506/26445451.html

Zevra Therapeutics, Inc. (ZVRA) Tops Q4 EPS by 53c

Wed, 06 May 2026 16:18:09 -0400

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) reported Q4 EPS of $0.60, $0.53 better than the analyst estimate of $0.07. Revenue for the quarter came in at $36.2 million versus the consensus estimate of $31.96 million.

For earnings history and earnings-related data on Zevra Therapeutics, Inc. (ZVRA) click here.

Form 8-K ZEVRA THERAPEUTICS, INC. For: May 06

Wed, 06 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260506/26443609.html

Form 8-K ZEVRA THERAPEUTICS, INC. For: May 06

Wed, 06 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260506/26443609.html

Form SCHEDULE 13G ZEVRA THERAPEUTICS, INC. Filed by: FMR LLC

Wed, 06 May 2026 11:44:00 -0400

si-local-file:///var/storage/secattach/20260506/26441824.html

Form SCHEDULE 13G ZEVRA THERAPEUTICS, INC. Filed by: FMR LLC

Wed, 06 May 2026 11:44:00 -0400

si-local-file:///var/storage/secattach/20260506/26441824.html

Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call

Wed, 22 Apr 2026 07:30:00 -0400

BOSTON, April 22, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced it will report corporate and financial results for the first quarter on Wednesday, May 6, 2026, via a news release after the market close, and will host a conference call/audio webcast at 4:30 p.m. ET that day.

A link to the audio webcast will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website

Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call

Wed, 22 Apr 2026 07:30:00 -0400

A link to the audio webcast will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website

Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call

Wed, 22 Apr 2026 07:30:00 -0400

A link to the audio webcast will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website

Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call

Wed, 22 Apr 2026 07:30:00 -0400

A link to the audio webcast will be accessible on the “Events & Presentations” page in the Investor Relations section of Zevra’s website

Form DEF 14A ZEVRA THERAPEUTICS, INC. For: Jun 04

Mon, 20 Apr 2026 09:01:00 -0400

si-local-file:///var/storage/secattach/20260420/26334813.html

Form DEF 14A ZEVRA THERAPEUTICS, INC. For: Jun 04

Mon, 20 Apr 2026 09:01:00 -0400

si-local-file:///var/storage/secattach/20260420/26334813.html

Form PRE 14A ZEVRA THERAPEUTICS, INC. For: Apr 06

Mon, 06 Apr 2026 09:02:00 -0400

si-local-file:///var/storage/secattach/20260406/26274779.html